advanced gastric cancer or colorectal cancer
Conditions
Interventions
3:Observation group
2:S-1 plus Xiangsha Liujunzi Decoction group
1:S-1 group
Sponsors
Affiliated hospital of Guangdong Medicine College
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Medical informed Consent must be signed by the patient or the witness; (2) The stage III/IV gastric cancer or colorectal cancer should be diagnosed by pathology or cytology; (3) The patients should be in control condition after chemotherapy (CR/PR/SD); (4) Aged from 18 to 75 years old; expected survival for more than 3 months; (5) The KPS score >=60; (6) According to RECIST 1.1, at least one target lesion is measurable; (7) Blood routine test: Hemoglobin>=90g/L; Neutrophil count>=1.5×10^9/LPlatelet count>=100×10^9/L; (8) Biochemical examination: STB=60ml/min.; (9) Heart and lung function is basically normal.
Exclusion criteria
Exclusion criteria: (1) The patients have heart, liver, kidney damage or abnormal bone marrow function at the same time; (2) The patients had other malignant tumors before or now, excepting the cutaneous basal cell carcinoma have been cured and the cervical carcinoma in situ; (3) The patients can not eat Chinese medicine because of poor body; (4) According to the investigator's judgment, there is a serious harm to the patient or the accompanying disease will obstruct patient to complete the study; (5) Pregnant or lactating women; (6) Being allergic to drugs used in the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Treatment effect; | — |
Countries
China
Contacts
Public ContactLiang Qilian
Affiliated hospital of Guangdong Medicine College
Outcome results
None listed